{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:00:44Z","timestamp":1790312444568,"version":"4.1.0"},"reference-count":60,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T00:00:00Z","timestamp":1539648000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"DOI":"10.3389\/fcimb.2018.00360","type":"journal-article","created":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T08:46:25Z","timestamp":1539679585000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["A Perspective on Thiazolidinone Scaffold Development as a New Therapeutic Strategy for Toxoplasmosis"],"prefix":"10.3389","volume":"8","author":[{"given":"Cristian","family":"Rocha-Roa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00e9stor","family":"Cardona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,10,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"273","DOI":"10.2147\/DDDT.S60973","article-title":"Drugs in development for toxoplasmosis: advances, challenges, and current status","volume":"11","author":"Alday","year":"2017","journal-title":"Drug Des. Dev. Ther."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1177\/0300060518757928","article-title":"Association between Toxoplasma gondii infection and history of blood transfusion: a case-control seroprevalence study","volume":"46","author":"Alvarado-Esquivel","year":"2018","journal-title":"J. Int. Med. Res."},{"key":"B3","unstructured":"Synthesis, anti-toxoplasma gondii and antimicrobial activities of 2-hydrazolyl-3-phenyl-5-(4-nitrobenzylidene)-4-thiazolidinone substituted derivatives15671573\n            AquinoT. M.\n            NascimentoA. A. P. L.\n            SpacovI. C. G.\n            CarvalhoC. S.\n            LimaV. T.\n            AlvesA. Q.\n          Am. J. Pharm.302011"},{"key":"B4","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ejps.2015.01.014","article-title":"Therapeutic index modeling and predictive QSAR of novel thiazolidin-4-one analogs against Toxoplasma gondii","volume":"70","author":"Asadollahi-Baboli","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The protein data bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jsb.2011.04.009","article-title":"Crystal structures of the free and inhibited forms of plasmepsin I (PMI) from Plasmodium falciparum","volume":"175","author":"Bhaumik","year":"","journal-title":"J. Struct. Biol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"8862","DOI":"10.1021\/bi201118z","article-title":"Structural insights into the activation and inhibition of histo-aspartic protease from Plasmodium falciparum","volume":"50","author":"Bhaumik","year":"","journal-title":"Biochemistry"},{"key":"B8","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.jmb.2009.03.011","article-title":"Crystal Structures of the Histo-Aspartic Protease (HAP) from Plasmodium falciparum","volume":"388","author":"Bhaumik","year":"2009","journal-title":"J. Mol. Biol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1080\/10409238.2017.1287161","article-title":"Dynamic protein S-palmitoylation mediates parasite life cycle progression and diverse mechanisms of virulence","volume":"52","author":"Brown","year":"2017","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.bbapap.2016.01.010","article-title":"Identification of new palmitoylated proteins in Toxoplasma gondii","volume":"1864","author":"Caballero","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"B11","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1080\/14756366.2017.1316494","article-title":"Synthesis and biological evaluation of anti- Toxoplasma gondii activity of a novel scaffold of thiazolidinone derivatives","volume":"32","author":"Carradori","year":"2017","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"B12","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1590\/S0100-879X2009005000038","article-title":"Anti-parasitic action and elimination of intracellular Toxoplasma gondii in the presence of novel thiosemicarbazone and its 4-thiazolidinone derivatives","volume":"43","author":"Carvalho","year":"2010","journal-title":"Braz. J. Med. Biol. Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"4574","DOI":"10.1021\/jm9005862","article-title":"Synthesis and evaluation of 4-acyl-2-thiazolylhydrazone derivatives for anti-Toxoplasma efficacy in vitro","volume":"52","author":"Chimenti","year":"2009","journal-title":"J. Med. Chem."},{"key":"B14","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1107\/S0907444905041260","article-title":"Structure of the aspartic protease plasmepsin 4 from the malarial parasite Plasmodium malariae bound to an allophenylnorstatine-based inhibitor","volume":"62","author":"Clemente","year":"2006","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"B15","doi-asserted-by":"publisher","first-page":"33","DOI":"10.7326\/0003-4819-116-1-33","article-title":"Treatment of toxoplasmic encephalitis in patients with AIDS: a randomized trial comparing pyrimethamine plus clindamycin to pyrimethamine plus sulfadiazine","volume":"116","author":"Dannemann","year":"1992","journal-title":"Ann. Intern. Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.sbi.2015.11.011","article-title":"Multiscale simulation of DNA","volume":"37","author":"Dans","year":"2016","journal-title":"Curr. Opin. Struct. Biol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ejmech.2014.08.046","article-title":"Design, synthesis and biological characterization of thiazolidin-4-one derivatives as promising inhibitors of Toxoplasma gondii","volume":"86","author":"D'Ascenzio","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"B18","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.bmc.2007.09.025","article-title":"Synthesis, anti-Toxoplasma gondii and antimicrobial activities of benzaldehyde 4-phenyl-3-thiosemicarbazones and 2-[(phenylmethylene)hydrazono]-4-oxo-3-phenyl-5-thiazolidineacetic acids","volume":"16","author":"de Aquino","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"B19","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1574-6968.2000.tb09043.x","article-title":"Hydroxyurea inhibits intracellular Toxoplasma gondii multiplication","volume":"185","author":"de Melo","year":"2000","journal-title":"FEMS Microbiol. Lett."},{"key":"B20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.cyto.2014.03.005","article-title":"Ocular cytokinome is linked to clinical characteristics in ocular toxoplasmosis","volume":"68","author":"de-la-Torre","year":"2014","journal-title":"Cytokine"},{"key":"B21","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/nrd.2018.21","article-title":"Kinase inhibitors: the road ahead","volume":"17","author":"Ferguson","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"B22","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.chom.2015.09.006","article-title":"Global analysis of palmitoylated proteins in Toxoplasma gondii","volume":"18","author":"Foe","year":"2015","journal-title":"Cell Host Microbe"},{"key":"B23","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1002\/jhet.5570450401","article-title":"Progress in the chemistry of 4- thiazolidinones","volume":"45","author":"Hamama","year":"2008","journal-title":"J. Heterocycl. Chem."},{"key":"B24","doi-asserted-by":"publisher","first-page":"3594","DOI":"10.1021\/jm901857d","article-title":"Thiazole, oxadiazole, and carboxamide derivatives of artemisinin are highly selective and potent inhibitors of Toxoplasma gondii","volume":"53","author":"Hencken","year":"2010","journal-title":"J. Med. Chem."},{"key":"B25","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.molbiopara.2008.11.012","article-title":"The cathepsin L of Toxoplasma gondii (TgCPL) and its endogenous macromolecular inhibitor, toxostatin","volume":"164","author":"Huang","year":"2009","journal-title":"Mol. Biochem. Parasitol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/nrmicro2858","article-title":"Modulation of innate immunity by Toxoplasma gondii virulence effectors","volume":"10","author":"Hunter","year":"2012","journal-title":"Nat. Rev. Microbiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"CD007417","DOI":"10.1002\/14651858.CD007417.pub2","article-title":"Corticosteroids as adjuvant therapy for ocular toxoplasmosis","volume":"4","author":"Jasper","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"B28","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/clpt.2009.293","article-title":"Deconstructing the drug development process: the new face of innovation","volume":"87","author":"Kaitin","year":"2010","journal-title":"Clin. Pharmacol. Ther."},{"key":"B29","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/clinids\/22.2.268","article-title":"Pyrimethamine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS","volume":"22","author":"Katlama","year":"1996","journal-title":"Clin. Infect. Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.bioorg.2017.10.014","article-title":"Synthetic and medicinal perspective of thiazolidinones: a review","volume":"75","author":"Kaur Manjal","year":"2017","journal-title":"Bioorg. Chem."},{"key":"B31","unstructured":"2D QSAR and Molecular docking studies of chloroquine-thiazolidinone derivatives as potential pfLDH inhibitors of Plasmodium falciparum4253\n            KaushikD.\n            PaliwalD.\n            KumarA.\n          Int. J. Pharmacol. Pharm. Sci22015"},{"key":"B32","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ijbiomac.2015.12.072","article-title":"Current updates on computer aided protein modeling and designing","volume":"85","author":"Khan","year":"2016","journal-title":"Int. J. Biol. Macromol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1002\/iub.306","article-title":"SAR and pharmacophore models for the rhodanine inhibitors of Plasmodium falciparum enoyl-acyl carrier protein reductase","volume":"62","author":"Kumar","year":"2010","journal-title":"IUBMB Life"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1007\/s00018-008-7556-x","article-title":"Host cell manipulation by the human pathogen Toxoplasma gondii","volume":"65","author":"Lalibert\u00e9","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.2174\/0929867324666171023163752","article-title":"Privileged structures in the design of potential drug candidates for neglected diseases","author":"Leite","year":"2017","journal-title":"Curr. Med. Chem"},{"key":"B36","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.bbapap.2011.06.002","article-title":"Proteases as regulators of pathogenesis: examples from the Apicomplexa","volume":"1824","author":"Li","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"B37","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.1016\/j.ejmech.2010.05.017","article-title":"Synthesis and evaluation of anti-Toxoplasma gondii and antimicrobial activities of thiosemicarbazides, 4-thiazolidinones and 1,3,4-thiadiazoles","volume":"45","author":"Liesen","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"B38","doi-asserted-by":"publisher","first-page":"3672","DOI":"10.1021\/jm00098a012","article-title":"Synthesis and antitumor activity of amino derivatives of pyridine-2-carboxaldehyde thiosemicarbazone","volume":"35","author":"Liu","year":"1992","journal-title":"J. Med. Chem."},{"key":"B39","doi-asserted-by":"publisher","first-page":"7017","DOI":"10.1128\/AAC.01176-16","article-title":"Review of experimental compounds demonstrating anti-toxoplasma activity","volume":"60","author":"McFarland","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4172\/2329-6674.1000123","article-title":"Drug discovery and in silico techniques: a mini-review","volume":"4","author":"Mohd Hassan","year":"2014","journal-title":"Enzym. Eng."},{"key":"B41","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/cmdc.201300354","article-title":"Structural design, synthesis and structure-activity relationships of thiazolidinones with enhanced anti- Trypanosoma cruzi activity","volume":"9","author":"Moreira","year":"2014","journal-title":"ChemMedChem"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1038\/aps.2012.109","article-title":"Computational drug discovery","volume":"33","author":"Ou-Yang","year":"2012","journal-title":"Acta Pharmacol. Sin."},{"key":"B43","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3347\/kjp.2013.51.4.393","article-title":"Clinical features and treatment of ocular toxoplasmosis","volume":"51","author":"Park","year":"2013","journal-title":"Korean J. Parasitol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"44","DOI":"10.4103\/0253-7184.81255","article-title":"Successful treatment of cerebral toxoplasmosis with cotrimoxazole","volume":"32","author":"Patil","year":"2011","journal-title":"Indian J. Sex. Transm. Dis."},{"key":"B45","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/9781118644843.ch16","article-title":"Pathogenesis of Toxoplasma gondii in Humans","volume-title":"Human Emerging and Re-emerging Infections","author":"Peng","year":"2015"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1056\/NEJM199212033272306","article-title":"Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome","volume":"327","author":"Porter","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"B47","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40169-017-0181-2","article-title":"A perspective on multi-target drug discovery and design for complex diseases","volume":"7","author":"Ramsay","year":"2018","journal-title":"Clin. Transl. Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nchembio.1199","article-title":"Target identification and mechanism of action in chemical biology and drug discovery","volume":"9","author":"Schenone","year":"2013","journal-title":"Nat. Chem. Biol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"874","DOI":"10.3389\/fphar.2018.00874","article-title":"New multitarget approaches in the war against glioblastoma: a mini-perspective","volume":"9","author":"Sestito","year":"2018","journal-title":"Front. Pharmacol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1124\/pr.112.007336","article-title":"Computational methods in drug discovery","volume":"66","author":"Sliwoski","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1002\/cmdc.201500301","article-title":"Development of small-molecule Trypanosoma brucei N-Myristoyltransferase inhibitors: discovery and optimisation of a novel binding mode","volume":"10","author":"Spinks","year":"2015","journal-title":"ChemMedChem"},{"key":"B52","doi-asserted-by":"publisher","first-page":"528","DOI":"10.4269\/ajtmh.2010.10-0082","article-title":"Prevalence and risk factors of toxoplasmosis among pregnant women in Fortaleza, Northeastern Brazil","volume":"83","author":"Sroka","year":"2010","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"B53","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1016\/j.bmcl.2005.03.048","article-title":"Synthesis of thiosemicarbazone and 4-thiazolidinone derivatives and their in vitro anti-Toxoplasma gondii activity","volume":"15","author":"Ten\u00f3rio","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B54","doi-asserted-by":"publisher","first-page":"E70","DOI":"10.3390\/molecules23010070","article-title":"Hydrazone derivatives enhance antileishmanial activity of thiochroman-4-ones","volume":"23","author":"Vargas","year":"2018","journal-title":"Molecules"},{"key":"B55","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/S1357-2725(03)00248-6","article-title":"Novel aroylhydrazone and thiosemicarbazone iron chelators with anti-malarial activity against chloroquine-resistant and -sensitive parasites","volume":"36","author":"Walcourt","year":"2004","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3390\/pathogens7010025","article-title":"Congenital toxoplasmosis: a plea for a neglected disease","volume":"7","author":"Wallon","year":"2018","journal-title":"Pathogens"},{"key":"B57","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.pt.2017.04.001","article-title":"Brains and brawn: toxoplasma infections of the central nervous system and skeletal muscle","volume":"33","author":"Wohlfert","year":"2017","journal-title":"Trends Parasitol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s11302-015-9485-0","article-title":"Scintillation proximity assay (SPA) as a new approach to determine a ligand's kinetic profile. A case in point for the adenosine A1 receptor","volume":"12","author":"Xia","year":"2016","journal-title":"Purinergic Signal."},{"key":"B59","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1002\/med.21290","article-title":"Comprehensive review in current developments of imidazole-based medicinal chemistry","volume":"34","author":"Zhang","year":"2014","journal-title":"Med. Res. Rev."},{"key":"B60","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.actatropica.2017.02.030","article-title":"Immunization with Toxoplasma gondii aspartic protease 3 increases survival time of infected mice","volume":"171","author":"Zhao","year":"2017","journal-title":"Acta Trop."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcimb.2018.00360\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T08:48:26Z","timestamp":1539679706000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcimb.2018.00360\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,16]]},"references-count":60,"alternative-id":["10.3389\/fcimb.2018.00360"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2018.00360","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,16]]},"article-number":"360"}}